Prevalence of HIV among Women with Vaginal Discharge in a Gynecological Clinic

Journal of the National Medical Association

Volumn 96, Issue 3, 2004, Pages 367-371

  Anorlu, Rose ^a   Imosemi, Donald ^a   Odunukwe, Nkiru ^b   Abudu, Olalekan ^a   Otuonye, Mirable ^b  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

HIV; Vaginal discharge

Indexed keywords

ADULT; ARTICLE; CANDIDA ALBICANS; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; FUNGUS ISOLATION; GARDNERELLA VAGINALIS; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NEISSERIA GONORRHOEAE; NIGERIA; PATIENT COUNSELING; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS; TRICHOMONAS VAGINALIS; VAGINA DISCHARGE;

ADOLESCENT; ADULT; CANDIDA ALBICANS; CANDIDIASIS; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; NIGERIA; PREVALENCE; VAGINAL DISCHARGE;

EID: 1442282386     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Abudu O. Vaginal Discharge. In: Textbook for Medical Students Volume II. Agboola AA(ed). Lagos: University Services Educational Publishers Ltd. pp 82-88.
2. National AIDS/STD Control Programme (Federal Ministry of Health). Syndromic Management of Sexually Transmitted Disease. 1996.
3. Fleming DT, Wasserheit JN. From epidemiology synergy to public health policy and practice, the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Dis. 1999;75:3-17.
4. Sewankanbo N, Gray RH, Waiver MJ, et al. HIV infection associated with abnormal vaginal flora morphology and bacteria vaginosis. Lancet. 1997;350:546-550.
5. Clemetson DBA, Moss GB, Willerford D, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993;269:2860-2864.
6. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(suppl III):5-7.
7. Kreiss J, Willerford D, Hansel M, et al. Association between cervical inflammation and cervical shedding of HIV DNA. J Infect Dis. 1994;175:56-62.
8. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis. 1998:167-174.
9. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women with nonulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS. 1999;13:327-332.
10. Dragi T, Litwin V, Allaway GP, et al. HIV entry into CD4+ cells is mediated by chemokine receptor CC-CKR-5. Nature. 1996;381:667-673.
11. Oladimeji AO, Ayata TT, Adewole F, et al. Clinicopathologic study of vaginal discharge in Ibadan. Nig Qt J Hosp Med. 1998;8:6-8.
12. National AIDS/STD Control Programme Federal Ministry of Health. HIV/Syphilis Sentinel Seroprevalence Survey in Nigeria. November 1999.
13. Minkoff HL, Eisenberger-Matityahu D, Feldman J, et al. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol. 1999;180:824-836.
14. Mostad SB, Overbaugh J, Devaange, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922-927.
15. Imam N, Carpenter CCJ, Mayer KH, et al. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med. 1990;89:142-146.
16. Duerr AC, Sierra MF, Feldman J, et al. Immunocompromise and prevalence of candida vulvovaginitis in HIV-infected women. Obstet Gynecol. 1997;90:252-256.
17. Williams AB, Andrews S, Tashima K, et al. Factors associated with vaginal yeast infections in HIV-positive women. J Assoc Nurses AIDS Care. 1998;9:47-52.
18. Cu-Uvin S, Hogan JW, Warren D, et al. Prevalence of lower genital tract infections among HIV-seropositive and high-risk HIV-seronegative women. Clin Infect Dis. 1999;29:1145-1150.
19. Nigeria Institute of Medical Research, Federal Ministry of Science and Technology. HIV/AIDS in Nigeria-Survey of Health and Laboratory Facilities: 1989-1999. Technical Report; 2000.